$8.33
-0.26 (-3.03%)
ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS)
CAPS Rating:
The Company is a biopharmaceutical company exploiting proprietary RNA-based drug discovery technologies to create a new class of drugs to treat important diseases.
RSS Headlines
Fool UK